Nursing homes as a reservoir of extended-spectrum -lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
Open Access
- 23 June 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (3) , 635-641
- https://doi.org/10.1093/jac/dkp220
Abstract
To assess the prevalence and risk factors for faecal carriage of fluoroquinolone-resistant, extended-spectrum β-lactamase (ESBL)-producing, Escherichia coli (MDR E. coli) among residents in nursing homes in Northern Ireland. Between January 2004 and May 2006, retrospective histories of hospital admissions, antimicrobial treatment and co-morbidities were collected. Faecal samples were cultured for MDR E. coli. These isolates and their ESBL genes were typed by a reference laboratory. Of the 294 patients included in the study, faecal samples from 119 (40.5%) grew MDR E. coli. The proportion of carriers in the different homes ranged from 0% to 75%. Epidemic strain A belonging to the ST131, O25:H4 lineage with the CTX-M-15 enzyme accounted for 58 (49%) of all isolates; its proportion varied from 0% to 100% among homes. Fifty-one percent of carriers had no history of recent hospital admission and only 13.5% had a known history of ESBL E. coli colonization or infection. In a multivariate logistic regression model, days of fluoroquinolone use [odds ratio (OR) = 1.33, 95% confidence interval (CI) 1.04–1.69, P = 0.02] and a history of urinary tract infection (OR = 2.56, 95% CI 1.37–4.78, P = 0.003) were the only variables independently associated with the risk of carrying MDR E. coli. The high level of faecal carriage of MDR E. coli in nursing home residents demonstrates their importance as a reservoir population. Public health measures to combat spread of these organisms should address the needs of this group.Keywords
This publication has 16 references indexed in Scilit:
- Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the communityClinical Microbiology & Infection, 2008
- CTX-M: changing the face of ESBLs in EuropeJournal of Antimicrobial Chemotherapy, 2006
- Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East EnglandJournal of Antimicrobial Chemotherapy, 2006
- Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trialBMJ, 2005
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized PatientsJournal of Clinical Microbiology, 2004
- Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: Resistance is a regional problemProceedings of the National Academy of Sciences, 2004
- Determination of minimum inhibitory concentrationsJournal of Antimicrobial Chemotherapy, 2001
- Multiple Antibiotic–Resistant Bacteria in Long‐Term‐Care Facilities: An Emerging Problem in the Practice of Infectious DiseasesClinical Infectious Diseases, 2000
- Multiple Antibiotic–Resistant Klebsiella and Escherichia coli in Nursing HomesJAMA, 1999